We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




First High-Precision Dual-Color Optoelectronic Brain Probe to Help Identify Origin of Brain Diseases

By HospiMedica International staff writers
Posted on 27 Dec 2023

Scientists have made a groundbreaking advancement by creating the first dual-color optoelectronic neural probe. More...

This innovative device stands out from previous single-color probes, which typically control brain activity in just one direction – excitation or inhibition, but not both. This new dual-color probe can simultaneously enhance and silence the electrical activities of the same neurons within precise layers of the brain's cortex and its deeper regions. This development is set to revolutionize the study of densely arranged neural microcircuits in the cortex and deeper brain areas, contributing significantly to the functional mapping of the brain. The ultimate goal is for the device to assist in identifying the origins of various brain disorders.

The device developed by a team of researchers at the University of Massachusetts Amherst (Amherst, MA, USA) utilizes optogenetics, a technique that employs light to control neural activity. The probe can emit either red or blue light into the brain, which respectively increases or decreases neuronal activity as confirmed by electrical neural recording signals. This feature, known as bidirectional optogenetic electrophysiology, is expected to significantly enhance the study of brain circuitry and provide insights into animal models of diseases.

Bidirectional control of neural activity is vital for advancing our understanding of conditions like epilepsy and Parkinson’s disease. However, building such devices is complex, requiring the integration of various optoelectronic materials into a compact space—less than one millimeter—with low crosstalk to each other. This research represents the initial test of this technology, demonstrating its capacity to provide a high spatial resolution and bidirectional control of the brain in mice. Looking ahead, the researchers plan to broaden the scope of their study to test the device's applications in other parts of the body beyond the brain.

Related Links:
University of Massachusetts Amherst 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Critical Care Cart
Avalo
New
Mattress System
Apollo Infant Dynamic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.